VAERS reports by lot

GSK Varicella/Shingles lot N3755: VAERS reports

38 VAERS reports list lot N3755 as a GSK Varicella/Shingles vaccine, received between 2022-03-22 and 2024-05-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
3%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)821%
Neurological615%
Musculoskeletal615%
Injection-site / Local reaction615%
Gastrointestinal513%
Cardiac / Cardiovascular410%
Dermatological (non-injection-site)38%
Allergic / Anaphylactic13%

Where reports came from

U.S. state of the reporter, where given (top 11).

District of Columbia19
North Carolina2
Delaware2
Kentucky2
Florida2
California2
Wisconsin1
Tennessee1
Illinois1
Maryland1
New York1

Reports by month received

2022-034
2022-045
2022-051
2022-061
2022-101
2023-127
2024-019
2024-022
2024-032
2024-044
2024-052

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.